AEterna Zentaris Inc (AEZS)
7.90
+0.06
(+0.77%)
USD |
NASDAQ |
May 10, 16:00
7.90
0.00 (0.00%)
After-Hours: 20:00
AEterna Zentaris Revenue (TTM): 4.498M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.498M |
| September 30, 2023 | 6.862M |
| June 30, 2023 | 8.719M |
| March 31, 2023 | 6.251M |
| December 31, 2022 | 5.64M |
| September 30, 2022 | 4.111M |
| June 30, 2022 | 3.303M |
| March 31, 2022 | 5.109M |
| December 31, 2021 | 5.26M |
| September 30, 2021 | 6.67M |
| June 30, 2021 | 5.746M |
| March 31, 2021 | 4.23M |
| December 31, 2020 | 3.652M |
| September 30, 2020 | 1.304M |
| June 30, 2020 | 1.459M |
| March 31, 2020 | 1.585M |
| December 31, 2019 | 0.532M |
| September 30, 2019 | 1.906M |
| June 30, 2019 | 2.286M |
| March 31, 2019 | 2.26M |
| December 31, 2018 | 26.88M |
| September 30, 2018 | 25.67M |
| June 30, 2018 | 25.24M |
| March 31, 2018 | 25.32M |
| December 31, 2017 | 0.923M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.049M |
| June 30, 2017 | 1.077M |
| March 31, 2017 | 0.93M |
| December 31, 2016 | 0.911M |
| September 30, 2016 | 0.709M |
| June 30, 2016 | 0.613M |
| March 31, 2016 | 0.714M |
| December 31, 2015 | 0.545M |
| September 30, 2015 | 0.454M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -15.89M |
| June 30, 2013 | -8.77M |
| March 31, 2013 | -1.395M |
| December 31, 2012 | 2.053M |
| September 30, 2012 | 5.399M |
| June 30, 2012 | 7.774M |
| March 31, 2012 | 6.826M |
| December 31, 2011 | 4.705M |
| September 30, 2011 | 33.40M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.532M
Minimum
Dec 2019
8.719M
Maximum
Jun 2023
4.164M
Average
4.23M
Median
Mar 2021
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |